Tonix Pharmaceuticals stock halted ahead of FDA approval news
Investing.com - Lowe’s (NYSE: LOW) reported fourth quarter EPS of $1.93, $0.12 better than the analyst estimate of $1.81. Revenue for the quarter came in at $18.55B versus the consensus estimate of $18.19B.
Guidance
Lowe’s sees Q1 2026 EPS of $12.15-$12.40 versus the analyst consensus of $12.48.
Lowe’s sees Q1 2026 revenue of $83.50B-$84.50B versus the analyst consensus of $84.77B.
Lowe’s’s stock price closed at $242.39. It is down -11.03% in the last 3 months and up 2.97% in the last 12 months.
Lowe’s saw 14 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Lowe’s’s stock price’s past reactions to earnings here.
According to InvestingPro, Lowe’s’s Financial Health score is "fair performance".
Check out Lowe’s’s recent earnings performance, and Lowe’s’s financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar